Kevin Centofanti

Kevin Centofanti

President at Brooks, Houghton & Co., Inc.

64 year
Finance
Consumer Services
Health Technology

Profile

Kevin Centofanti is currently a Senior Managing Director at Brooks Houghton & Co. (Private Equity), a Member at Securities Investor Protection Corp., the President at Brooks, Houghton & Co., Inc., and a Member at Financial Industry Regulatory Authority, Inc. He previously worked as a Director at Generex Biotechnology Corp., a Managing Director at WR Hambrecht + Co. LLC, a Managing Director at W.R.
Hambrecht + Co., Inc., a Principal at Daiwa Capital Markets America, Inc., and a Partner at Nassau Group, Inc. Centofanti holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from State University of New York at Buffalo.

Kevin Centofanti active positions

CompaniesPositionStart
Private Equity Investor 2010-05-13
Corporate Officer/Principal -
Corporate Officer/Principal -
President -
All active positions of Kevin Centofanti

Former positions of Kevin Centofanti

CompaniesPositionEnd
GENEREX BIOTECHNOLOGY CORPORATION Director/Board Member 2019-03-31
Nassau Group, Inc. Corporate Officer/Principal 2001-12-31
Private Equity Investor 2000-12-31
Corporate Officer/Principal 1999-12-31
Corporate Officer/Principal -
See the detail of Kevin Centofanti's experience

Training of Kevin Centofanti

The Trustees of Columbia University in The City of New York Masters Business Admin
State University of New York at Buffalo Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Centofanti's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies9

Health Technology

Finance

Nassau Group, Inc.

Finance

Finance

Finance

Commercial Services

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Kevin Centofanti